A collaboration between HHMI’s SEA PHAGES program and physicians at London’s Great Ormond Street Hospital result in the successful compassionate use of engineered bacteriophage to treat a drug resistant mycobacterium infection in a teenager who received a double lung transplant. As reported by NPR.